Santen Pharmaceutical Profile

14.73
USD 0.24  1.6%

Santen Pharmaceutical Summary

Santen Pharmaceutical Co Ltd (SNPHY) is traded on OTC Market in USA and employs 3,805 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 5.84B. Santen Pharmaceutical classifies itself under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 407.09M outstanding shares. SANTEN PHARMACEUT has accumulated about 683.23M in cash with 348.35M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.68.
Check Santen Pharmaceutical Probability Of Bankruptcy

Ownership Allocation (%)

Santen Pharmaceutical Target Price Odds Analysis

Odds Below 14.73HorizonTargetOdds Above 14.73
50.49%30 days 14.73 49.23%
Based on normal probability distribution, the odds of Santen Pharmaceutical to move above current price in 30 days from now is about 49.23% (This Santen Pharmaceutical Co Ltd probability density function shows the probability of Santen Pharmaceutical Stock to fall within a particular range of prices over 30 days) .

Santen Pharmaceutical Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Lenox Wealth Advisors LlcCommon Shares94.01000
Parametric Portfolio Associates LlcCommon Shares1 M14.8 M
View Santen Pharmaceutical Diagnostics

Santen Pharmaceutical Risk Profiles

Santen Pharmaceutical Key Fundamentals

Santen Pharmaceutical Against Markets

Santen Pharmaceutical Current Performance Grades

Risk Adjusted
Performance Score (0 to 100)
0
Chance of
Financial Distress (0 to 100%)
51%
Equity ratings for Santen Pharmaceutical Co Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more

Santen Pharmaceutical Vital Trading Data

Santen Pharmaceutical Co., Ltd. researches and develops, produces, and markets pharmaceuticals and medical devices in Japan and internationally. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan. Santen Pharmaceutical operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 3805 people. more
NameSanten Pharmaceutical Co Ltd
CEOAkira KurokawaView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressGrand Front Osaka Tower A
ExchangeOTC Market
SectorHealthcare
IndustryDrug Manufacturers - Major
BenchmarkDOW
Websitewww.santen.com
Phone81 6 6321 7000
CurrencyUSD - US Dollar
Next Fiscal Year EndMarch 31, 2020
Most Recent QuarterDecember 31, 2018
Last Fiscal Year EndMarch 31, 2018

Santen PharmaceuticalCorporate Directors

Satoshi Suzuki Executive Officer, Chief Director of Planning
Kanoko Ohishi Independent Director
Kenji Morishima Executive Officer, Chief Director of Human Resources & Organization Development and CSR
Also please take a look at World Market Map. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Search macroaxis.com